Literature DB >> 2735327

Protection of rat gastric mucosa by sucralfate. Effects of luminal stasis and of inhibition of prostaglandins synthesis.

G P Morris1, C M Keenan, W K MacNaughton, J L Wallace, T E Williamson.   

Abstract

Studies using a gastric chamber model demonstrated that sucralfate protected the rat gastric mucosa against hemorrhagic erosions induced by 40 percent ethanol and by acidified 80 mM sodium taurocholate. Protection required continuous contact of sucralfate with the gastric mucosa but it occurred without the production, by sucralfate alone, of significant damage to the luminal epithelium. Ultrastructural examination indicated that sucralfate stimulated mucus secretion by surface epithelial cells. Furthermore, sucralfate was "cytoprotective" in that, in addition to its anti-ulcer effects, it significantly reduced the damaging effects of luminal ethanol on the surface epithelium. Luminal stasis also significantly reduced the extent of hemorrhagic erosions produced by both ethanol and sodium taurocholate, but the most effective reduction in erosions occurred when sucralfate and luminal stasis were combined. Pretreatment with indomethacin abolished the protection provided by luminal stasis, but this protection was restored by sucralfate. Thus, these studies suggest that protection of the gastric mucosa by sucralfate results in part from effects on the unstirred layer. Sucralfate or its products also interact with the epithelial cells and stimulate mucus release and synthesis or release of inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2735327     DOI: 10.1016/0002-9343(89)90150-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture.

Authors:  M Romano; M Razandi; K J Ivey
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

2.  Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques.

Authors:  P E O'Brien; G Frydman; R Holmes; C Malcontenti; D Phelan
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

3.  Utilization of a human intestinal epithelial cell culture system (Caco-2) for evaluating cytoprotective agents.

Authors:  A S Tang; P J Chikhale; P K Shah; R T Borchardt
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

4.  A novel evaluation method of gastric mucoadhesive property in vitro and the mucoadhesive mechanism of tetracycline-sucralfate acidic complex for eradication of Helicobacter pylori.

Authors:  Shoichi Higo; Kazutomo Ori; Hirofumi Takeuchi; Hiromitsu Yamamoto; Tomoaki Hino; Yoshiaki Kawashima
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

5.  Topical nicotine protects rat gastric mucosa against ASA-induced damage. A role for mucosal fluid secretion in cytoprotection.

Authors:  C A Fallone; G P Morris
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

6.  Acid suppression therapy and allergic reactions.

Authors:  Eva Untersmayr
Journal:  Allergo J Int       Date:  2015-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.